Could a monthly infusion slow Alzheimer's? new trial tests sabirnetug
Disease control
Ongoing
This study tests a new drug called sabirnetug, given as a monthly IV infusion, to see if it can slow down memory loss and daily function decline in people with early Alzheimer's disease. About 542 participants will receive either the drug or a placebo. The goal is to measure chan…
Phase: PHASE2 • Sponsor: Acumen Pharmaceuticals • Aim: Disease control
Last updated May 26, 2026 09:28 UTC